Since Tat is expressed in the brain at relative high levels while the viral load is controlled in blood, this may, at least in part, explain why some HIV-1 patients still develop PML despite having a good access to cART [39]. The gene discussed is TAT; the disease is progressive multifocal leukoencephalopathy.